{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:26:16Z","timestamp":1761675976857,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.contraception.2012.01.006","type":"journal-article","created":{"date-parts":[[2012,8,15]],"date-time":"2012-08-15T11:36:54Z","timestamp":1345030614000},"page":"220-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Drospirenone- and levonorgestrel-containing oral contraceptives and the risk of gallbladder disease"],"prefix":"10.1016","volume":"86","author":[{"given":"Susan","family":"Jick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinci","family":"Pennap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2012.01.006_bb0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM197401032900104","article-title":"Boston Collaborative Drug Surveillance Program: surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy","volume":"290","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2012.01.006_bb0010","first-page":"1399","article-title":"Boston Collaborative Drug Surveillance Program: oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease and breast tumors","volume":"1","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2012.01.006_bb0015","series-title":"Oral contraceptives and health","first-page":"57","author":"Royal College of General Practitioners","year":"1974"},{"key":"10.1016\/j.contraception.2012.01.006_bb0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/030006057500300201","article-title":"Gallstones and oral contraceptives","volume":"3","author":"Howat","year":"1975","journal-title":"J Int Med Res"},{"key":"10.1016\/j.contraception.2012.01.006_bb0025","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2105\/AJPH.83.8.1113","article-title":"Oral contraceptives and the risk of gallbladder disease: a meta analysis","volume":"83","author":"Thijs","year":"1993","journal-title":"Am J Public Health"},{"year":"2010","series-title":"CTV.ca news staff. Yasmin\/Yaz birth control pill users launch lawsuit","key":"10.1016\/j.contraception.2012.01.006_bb0030"},{"author":"Anderson","key":"10.1016\/j.contraception.2012.01.006_bb0035"},{"author":"Newsome Law Firm","key":"10.1016\/j.contraception.2012.01.006_bb0040"},{"key":"10.1016\/j.contraception.2012.01.006_bb0045","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1503\/cmaj.110161","article-title":"Oral contraceptives and the risk of gallbladder disease: a comparative safety study","volume":"183","author":"Etminan","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.contraception.2012.01.006_bb0050","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptive with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2012.01.006_bb0055","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1365-2125.2002.01606.x","article-title":"Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive pill","volume":"53","author":"Black","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2012.01.006_bb0060","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/pds.1346","article-title":"Gallbladder disease in the general population: association with cardiovascular morbidity and therapy","volume":"16","author":"Gonz\u00e1lez-P\u00e9rez","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412000078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412000078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:45:02Z","timestamp":1761432302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782412000078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0010782412000078"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2012.01.006","relation":{},"ISSN":["0010-7824"],"issn-type":[{"type":"print","value":"0010-7824"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drospirenone- and levonorgestrel-containing oral contraceptives and the risk of gallbladder disease","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2012.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}